Research

Clinical research site in Durham, North Carolina · 800 PARK OFFICE DR, SUITE 3410, DURHAM, NC 27709-2770 · (919) 355-6449

As of July 2026, 19 paid clinical trials are recruiting at Research in Durham, North Carolina. Active studies at this site cover conditions such as ATTR Amyloidosis, Cutaneous Sarcoidosis and Generalized Myasthenia Gravis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Research (19)

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for Lichen Planopilaris

47 locations incl. Birmingham

Sponsor: Priovant Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07532603·Phase 2, Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for End Stage Kidney Disease

147 locations incl. Decatur

Sponsor: CSL Behring

Sex: All·Age: 18+

Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022

Apply to this trial

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for High Risk Cardiovascular Disease

261 locations incl. Birmingham

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

for Primary Generalized Tonic-Clonic Seizures

51 locations incl. Mobile

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 12+

Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

for Sjögren's Syndrome

31 locations incl. Avondale

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT06747949·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

for Pediatric

25 locations incl. Phoenix

Sponsor: Cytokinetics

Sex: All·Age: 12 - 17

Code: NCT06412666·Phase 2, Phase 3·Recruiting·Listed May 2024

Apply to this trial

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for Generalized Myasthenia Gravis

32 locations incl. Birmingham

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT04202341·Recruiting·Listed Dec 2019

Apply to this trial

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

for Alzheimer Disease

11 locations incl. Los Alamitos

Sponsor: Eli Lilly and Company

Sex: All·Age: 45 - 85·Accepts healthy volunteers

Code: NCT06657768·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

for Lupus Erythematosus, Systemic

19 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT06581198·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

for Transthyretin-Mediated Amyloidosis

12 locations incl. La Jolla

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: All ages

Code: NCT04561518·Recruiting·Listed Sep 2020

Apply to this trial

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

for Cardiovascular

7 locations incl. Jacksonville

Sponsor: CRISPR Therapeutics AG

Sex: All·Age: 18 - 75

Code: NCT07491172·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

8 locations incl. Torrance

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1 - 100

Code: NCT05868629·Recruiting·Listed May 2023

Apply to this trial

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

for Glycogen Storage Disease Type II Infantile Onset

6 locations incl. Gainesville

Sponsor: Amicus Therapeutics

Sex: All·Age: Up to 17

Code: NCT04808505·Phase 3·Recruiting·Listed Mar 2021

Apply to this trial

A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)

for Cutaneous Sarcoidosis

4 locations incl. San Francisco

Sponsor: Priovant Therapeutics, Inc.

Sex: All·Age: 18 - 75

Code: NCT06978725·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction

for Heart Failure

1 location in Durham

Sponsor: Duke University

Sex: All·Age: 18+

Code: NCT06733012·Recruiting·Listed Dec 2024

Apply to this trial

Ferric Citrate and Chronic Kidney Disease in Children

for Chronic Kidney Diseases

18 locations incl. Los Angeles

Sponsor: University of California, Los Angeles

Sex: All·Age: 6 - 18

Code: NCT04741646·Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

for Advanced Ovarian Carcinoma

12 locations incl. Miami

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT04575935·Phase 3·Recruiting·Listed Oct 2020

Apply to this trial

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

for Chronic Graft Versus Host Disease

1 location in Durham

Sponsor: Stefanie Sarantopoulos, MD, PhD.

Sex: All·Age: 18 - 80

Code: NCT06233110·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children

for Acute Pain

1 location in Durham

Sponsor: Duke University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06164028·Recruiting·Listed Dec 2023

Apply to this trial

More research sites in Durham

Duke University Medical Center (273 trials)
Duke University (194 trials)
Duke University Hospital (55 trials)
Duke University Health System (47 trials)
Duke Cancer Institute (39 trials)
Durham VA Medical Center, Durham, NC (30 trials)
Duke Cancer Center (28 trials)
Durham VA Medical Center (16 trials)
Duke University School of Medicine (13 trials)
Duke Eye Center (12 trials)

Explore more

Paid clinical trials in Durham, NC · North Carolina clinical trials